Improvement of self-reported physical functioning with tiotropium/olodaterol in Central and Eastern European COPD patients

A. Valipour (Wien, Austria), M. Tamm (Basel, Switzerland), J. Kociánová (Ostrava-Poruba, Czech Republic), V. Bayer Zubek (Biberach an der Riss, Germany), A. Medvedchikov (Vienna, Austria), M. Haaksma Herczegh (Vienna, Austria), J. Mucsi (Gödöllo, Hungary), Z. Fridlender (Jerusalem, Israel), C. Toma (Bucharest, Romania), A. Belevsky (Moscow, Russian Federation), B. Matula (Nitra, Slovakia), J. Šorli (Topolšica, Slovenia)

Source: International Congress 2018 – Primary care management of COPD
Session: Primary care management of COPD
Session type: Thematic Poster
Number: 912
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Valipour (Wien, Austria), M. Tamm (Basel, Switzerland), J. Kociánová (Ostrava-Poruba, Czech Republic), V. Bayer Zubek (Biberach an der Riss, Germany), A. Medvedchikov (Vienna, Austria), M. Haaksma Herczegh (Vienna, Austria), J. Mucsi (Gödöllo, Hungary), Z. Fridlender (Jerusalem, Israel), C. Toma (Bucharest, Romania), A. Belevsky (Moscow, Russian Federation), B. Matula (Nitra, Slovakia), J. Šorli (Topolšica, Slovenia). Improvement of self-reported physical functioning with tiotropium/olodaterol in Central and Eastern European COPD patients. 912

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: